Related Experiment Video
Updated: Mar 3, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal
Faraz S Ahmad1, Xuan Cai2, Katherine Kunkel3
1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Insights
Blacks with chronic kidney disease (CKD) have higher rates of left ventricular hypertrophy (LVH), a marker of heart disease. This study found Black race independently associated with concentric LVH in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Medical Genetics
Background:
- Chronic kidney disease (CKD) increases cardiovascular disease (CVD) risk, particularly in Black populations.
- Left ventricular hypertrophy (LVH) is a key subclinical CVD marker, but its racial variations in CKD patients are understudied.
Purpose of the Study:
- To compare the prevalence of different left ventricular (LV) remodeling types across racial/ethnic groups in individuals with CKD.
- To determine if race/ethnicity is independently associated with specific LV remodeling patterns, adjusting for confounders.
Main Methods:
- Cross-sectional analysis of the Chronic Renal Insufficiency Cohort Study.
- Compared LV geometry types (concentric hypertrophy, eccentric hypertrophy, concentric remodeling) between non-Hispanic Black and non-Hispanic White participants.
- Utilized multinomial logistic regression to assess independent associations between race/ethnicity and LV remodeling.
Main Results:
- Identified 1,164 non-Hispanic Black and 1,155 non-Hispanic White participants with adequate echocardiogram data.
- Non-Hispanic Blacks exhibited higher mean LV mass index and a greater prevalence of concentric LVH compared to non-Hispanic Whites.
- Black race/ethnicity was independently linked to increased odds of concentric LVH, even after accounting for factors like blood pressure and antihypertensive medication use.
Conclusions:
- Significant racial differences in LV mass and hypertrophic morphology exist among CKD patients.
- Findings highlight potential contributors to racial disparities in CVD outcomes within the CKD population.
- Further research is warranted to investigate the impact of LVH prevalence on CVD disparities in CKD.
Background:
Chronic kidney disease (CKD) is associated with increased risk of cardiovascular disease (CVD) and it is especially common among Blacks. Left ventricular hypertrophy (LVH) is an important subclinical marker of CVD, but there are limited data on racial variation in left ventricular structure and function among persons with CKD.
Methods:
In a cross-sectional analysis of the Chronic Renal Insufficiency Cohort Study, we compared the prevalence of different types of left ventricular remodeling (concentric hypertrophy, eccentric hypertrophy, and concentric remodeling) by race/ethnicity. We used multinomial logistic regression to test whether race/ethnicity associated with different types of left ventricular remodeling independently of potential confounding factors.
Results:
We identified 1,164 non-Hispanic Black and 1,155 non-Hispanic White participants who completed Year 1 visits with echocardiograms that had sufficient data to categorize left ventricular geometry type. Compared to non-Hispanic Whites, non-Hispanic Blacks had higher mean left ventricular mass index (54.7 ± 14.6 vs. 47.4 ± 12.2 g/m2.7; P < 0.0001) and prevalence of concentric LVH (45.8% vs. 24.9%). In addition to higher systolic blood pressure and treatment with >3 antihypertensive medications, Black race/ethnicity was independently associated with higher odds of concentric LVH compared to White race/ethnicity (odds ratio: 2.73; 95% confidence interval: 2.02, 3.69).
Conclusion:
In a large, diverse cohort with CKD, we found significant differences in left ventricular mass and hypertrophic morphology between non-Hispanic Blacks and Whites. Future studies will evaluate whether higher prevalence of LVH contribute to racial/ethnic disparities in cardiovascular outcomes among CKD patients.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury II: Pathophysiology

